A useful blood test should leave you with a clearer next step. Perhaps you need a repeat sample after recovering from a hard training week. Perhaps your prescriber needs to review a rising hematocrit. Sometimes the most useful finding is that the panel did not measure the thing you were worried about. Reading blood work well means getting to that next step without treating every red flag as a diagnosis or every green result as permission to carry on.
This guide is for people lifting seriously, using prescribed testosterone replacement therapy, or trying to understand the health effects of anabolic androgenic steroids. Those situations overlap, but they are not medically equivalent. Evidence about testosterone replacement in men with diagnosed deficiency cannot establish the safety of bodybuilding doses or combinations of drugs.
Start by putting the complete laboratory report beside your previous results. Have a short note of your medication, supplement use, recent training and symptoms. You do not need to memorize fifty reference ranges. You need a reliable way to check what was measured, what changed and what deserves follow-up.
First, check that you are reading the right result
Confirm the collection date, your identifying details and the units. The report date may be several days later than the blood draw. A historical result printed in the next column can look like the latest measurement, especially when a laboratory uses a crowded PDF layout. This matters when you are trying to match a result to an injection, illness or change in treatment.
Units are part of the measurement. Testosterone reported in nmol/L cannot be compared directly with a value in ng/dL. Hemoglobin may appear in g/L or g/dL; hematocrit can appear as a percentage or a fraction. Before deciding that a result has doubled or collapsed, check the units and the laboratory's own interval. If you upload the PDF into an app, compare the imported values with the original.
Look for qualifiers such as “greater than,” “less than,” or a note about an unsuitable sample. A testosterone result above the assay's measuring limit is not an exact concentration. A hemolyzed sample means some blood cells broke during collection or processing; that can affect particular results. Ask the laboratory or clinician whether a flagged sample needs repeating.
Understand the three comparisons on the page
A reference interval describes results in a defined reference population, commonly the central 95%. It helps identify values that are unusual. It does not draw a perfect boundary between health and disease. Laboratories establish or verify these intervals for their methods; they are not simply averages from people who never exercise. The CLSI reference-interval standard explains that process.
A clinical decision threshold answers a different question: at what result should a particular diagnosis, investigation or treatment be considered? Such thresholds may come from outcome research or professional guidance. They can depend on the condition, the treatment and the person. A software “athletic range” cannot replace them merely because a drug commonly pushes a marker outside the laboratory interval.
Your personal baseline adds a third comparison. A value that has changed substantially from your usual level deserves attention even if it remains inside the printed interval. Equally, a stable abnormal result still needs an explanation. Stability is useful evidence; it is not proof of safety. Our guide to what reference ranges actually mean explores these differences in more detail.
Read related markers together
For kidney assessment, creatinine and creatinine-based eGFR belong together because the latter is calculated partly from the former. Extra muscle, recent strenuous exercise and some supplements can influence creatinine. When that makes the estimate uncertain, a clinician may add cystatin C and calculate a combined estimate. Urine albumin-to-creatinine ratio, or uACR, checks for a different sign of kidney damage that a blood-only panel can miss.
The KDIGO kidney guideline recommends evaluating filtration and urine albumin in people at risk and confirming abnormalities. One low eGFR does not establish chronic kidney disease. A normal cystatin C does not rule out every kidney problem either. Interpretation includes change over time, blood pressure, urine findings, symptoms and whether an acute problem is possible.
For liver assessment, AST and ALT are enzymes that can rise after muscle injury as well as liver injury. CK, an enzyme associated with muscle damage, helps establish whether recent training could be contributing. GGT, alkaline phosphatase and bilirubin add information about the liver and bile system. They are supporting evidence, not a binary test that labels every enzyme rise as either harmless training or liver disease.
For cardiovascular assessment, read LDL cholesterol, non-HDL cholesterol, triglycerides and ApoB alongside blood pressure and your medical history. ApoB helps estimate the number of circulating particles capable of contributing to atherosclerosis. A favorable result does not evaluate heart muscle structure, rhythm or every effect of steroid exposure. The HAARLEM prospective study documented unfavorable changes in several cardiovascular markers during androgen use; being a predictable drug effect did not make those changes beneficial.
Give hormones their proper context
Total testosterone is the amount measured in circulation, including testosterone bound to proteins. SHBG is one of those binding proteins. When SHBG is unusually low or high, total testosterone can be harder to interpret on its own. Depending on the question, a clinician may use a reliable free-testosterone measurement or an appropriately calculated estimate.
Timing matters. A sample after an injection and a sample near the next dose may represent different parts of the same treatment pattern. Record the formulation and time since the last dose. Follow your prescriber's monitoring instructions rather than moving the injection to make the number look better. For diagnosis before treatment, the Endocrine Society guideline requires compatible symptoms and consistently low, accurately measured testosterone, with repeat morning testing.
LH and FSH are signals involved in testicular hormone production and sperm production. Exogenous androgens commonly suppress them. That helps explain a result, but suppression still matters if fertility or recovery after stopping is the question. A normal testosterone concentration while using an external hormone cannot demonstrate that your own production has recovered.
Decide what needs attention first
Begin with symptoms and any urgent instructions from the laboratory. Chest pain, severe breathlessness, stroke-like symptoms or fainting need medical assessment regardless of whether the last panel looked reassuring. Do not wait for a dashboard score or routine retest to investigate an acute problem.
Next, identify results that cross treatment-specific thresholds or have changed rapidly. Hematocrit, the proportion of blood volume occupied by red cells, is a good example. Testosterone can raise it. The Endocrine Society TRT guideline uses hematocrit above 54% as a point to withhold treatment and assess contributing factors under clinical care. That is an action threshold, not a claim that every lower result is safe or every higher result causes an immediate clot.
Then review persistent or unexplained abnormalities and longer-term risk factors. A rising ApoB or repeatedly elevated blood pressure may deserve a treatment conversation without producing symptoms today. The order is practical: immediate problems first, significant abnormalities next, then prevention and follow-up. Counting red flags without considering their meaning can reverse those priorities.
Use a repeat test to answer a specific question
A repeat sample is most useful when you know why you are repeating it. If recent strenuous lifting may have raised AST, ALT and CK, a clinician may arrange a draw after a suitable period without hard exercise. The necessary interval varies with the session and the degree of muscle injury. Do not assume one rest day removes every training effect.
If the concern is a treatment-related change, the repeat should be timed to the treatment and the marker involved. If the concern is a potentially important acute abnormality, repeating it weeks later may be inappropriate. Ask who will review the result and what would change the plan. Testing without a review pathway can create a growing folder of numbers and very little useful care.
Keep preparation consistent where possible: similar collection time, appropriate fasting if requested, ordinary hydration and a clear medication record. Consistency makes comparison easier. It should never involve stopping prescribed medicine, deliberately dehydrating or drinking excessive water to manipulate a result. See the blood-draw preparation guide for a practical routine.
Work through a realistic example
Imagine you booked routine blood work for Monday morning after a demanding Saturday session. AST and CK are higher than on your previous report. Your first instinct may be to blame the training, and that is a reasonable possibility. The useful question is what evidence would support that explanation. Look at the rest of the liver panel, any symptoms, the size of the increase and whether you recently started a medicine or supplement. Your clinician can decide whether a rested repeat is appropriate or whether further assessment should happen sooner.
Now suppose the same report shows a rise in hematocrit and your home blood-pressure readings have been climbing for several weeks. A heavy workout does not explain the entire picture. Those changes deserve their own review, including your testosterone exposure, measurement technique and possible contributors such as sleep apnea. Treating the whole panel as “just training” would lose the most useful information in it.
This is a hypothetical example, not a diagnostic rule. It illustrates a habit worth developing: give each explanation a boundary. Training may explain part of the report. Medication may explain another part. Neither explanation tells you, by itself, whether the change needs action. That is why keeping an honest training and medication record is more useful than searching for a reason to dismiss every flag.
Turn the report into a short appointment note
Write down the main question in one sentence. For example: “My hematocrit has increased on the same testosterone prescription; do we need to assess the dose, sleep apnea or another cause?” That gives the appointment a focus while leaving the diagnosis open. Add the current value, the previous value, the collection dates and any symptoms.
Bring the complete reports, not just cropped screenshots of the red rows. Include home blood-pressure readings if you have them and explain how you measured them. List nonprescribed compounds honestly, including approximate dates. A clinician cannot interpret suppression, liver abnormalities or unexpected hormone results properly if an important exposure is missing from the history.
Finish the review with three things written down: what needs action, what needs clarification and when the next review should happen. Those are more useful than trying to force every marker into a green category. The purpose of learning this skill is to participate in better decisions about your health, with the laboratory report serving as evidence rather than a verdict.